Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Voluntary suspension of Oxygent phase III trial announced by Alliance

Jan. 12, 2001

Scriptgen describes new antisickling agents identified using a novel method

Jan. 11, 2001

Novel glucose uptake enhancers presented by Telik

Jan. 11, 2001

Small-molecule insulin sensitizer slated to begin human testing next month

Jan. 11, 2001

Mechanism by which metformin lowers glucose production elucidated

Jan. 11, 2001

GnRH receptor antagonists designed by Neurocrine Biosciences group

Jan. 10, 2001

Ligand receives milestone payment from Wyeth-Ayerst; TSE-424 development continues

Jan. 10, 2001

Cholesterol-lowering effects of Sch-48461 demonstrated in primary hypercholesterolemia

Jan. 10, 2001

Ferring designs very-long-acting GnRH antagonist with other advantageous properties

Jan. 9, 2001

IND submitted for salmon calcitonin as oral osteoporosis treatment

Jan. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...